Anna U. Loengard - 03 Jan 2024 Form 4 Insider Report for CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)

Role: Director
Signature: /s/ Scott Leffler as attorney-in-fact for Anna U. Loengard
Issuer symbol: CLOV
Transactions as of: 03 Jan 2024
Net transactions value: +$199,999
Form type: 4
Filing time: 05 Jan 2024, 16:30:34 UTC
Previous filing: 08 Sep 2023
Next filing: 18 Mar 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CLOV	Class A Common Stock	Award	$199,999	+206,185	+105%	$0.9700	401,841	03 Jan 2024	Direct	F1
holding	CLOV	Class A Common Stock						10,000	03 Jan 2024	By Spouse IRA
holding	CLOV	Class A Common Stock						1,300	03 Jan 2024	By Son in a Custodial Account
holding	CLOV	Class A Common Stock						1,500	03 Jan 2024	By Daughter in a Custodial Account

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares of Class A Common Stock underlying an award of time-based restricted stock units (RSUs). The RSUs will vest in full on the first anniversary of January 3, 2024, subject to the Reporting Person's continued service as a director through such vesting date.

Remarks:

Ex. 24 - POA